Moreover, microwave ablation in combination with the ALK5 inhibitor SB-525334 effectively inactivates the TGF-β1/Smad2/Smad3 pathway, reducing the survival rate of HCC cells and promoting apoptosis (132). The gene discussed is TGFB1; the disease is hepatocellular carcinoma.